We meet our partners where they are in the product life cycle and enable their work with our array of technology platforms, end-to-end capabilities and industry insights so they can bring their original concepts to commercialization.
Building a first-of-its kind offering of enabling technologies and end-to-end capabilities to advance the work of the entire cell and gene therapy industry
Our team of world-class scientists, builders and operators use their deep industry expertise to equip our partners every step of the way.
Learn more about ElevateBio and how our team of industry experts are enabling the cell and gene therapy industry
From our Chairman and CEO, David HallalRead More
By: Mercedes Segura, Vice President, Process Development, ElevateBio, Dawn Maier, Vice President, Emerging Technologies, ElevateBio, and Bojiao Yin, Director of Vector Process Development, ElevateBioRead More
Wherever you are in your cell and gene therapy (CGT) product life cycle, we come alongside you to strengthen and accelerate the development of life-transformative CGTs.